208 related articles for article (PubMed ID: 31397224)
1. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
2. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
Thompson LDR
Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
[TBL] [Abstract][Full Text] [Related]
3. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
8. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome.
Wong KS; Dong F; Telatar M; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Afkhami M; Barletta JA
Thyroid; 2021 Jun; 31(6):933-940. PubMed ID: 33143568
[No Abstract] [Full Text] [Related]
9. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
10. Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy Alone.
Ghossein R; Ganly I; Tuttle RM; Xu B
Thyroid; 2023 May; 33(5):586-592. PubMed ID: 36884299
[No Abstract] [Full Text] [Related]
11. Follicular carcinoma.
Franssila KO; Ackerman LV; Brown CL; Hedinger CE
Semin Diagn Pathol; 1985 May; 2(2):101-22. PubMed ID: 3843689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
Akaishi J; Kondo T; Sugino K; Ogimi Y; Masaki C; Hames KY; Yabuta T; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Katoh R; Ito K
World J Surg; 2019 Sep; 43(9):2235-2244. PubMed ID: 31098668
[TBL] [Abstract][Full Text] [Related]
15. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients.
Goldstein NS; Czako P; Neill JS
Mod Pathol; 2000 Feb; 13(2):123-30. PubMed ID: 10697268
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study.
Rivera M; Ricarte-Filho J; Patel S; Tuttle M; Shaha A; Shah JP; Fagin JA; Ghossein RA
Hum Pathol; 2010 Feb; 41(2):172-80. PubMed ID: 19913280
[TBL] [Abstract][Full Text] [Related]
17. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
[TBL] [Abstract][Full Text] [Related]
18. Does the presence of capsule influence prognosis in poorly differentiated thyroid carcinoma?
Gubbiotti MA; Andrianus S; Sakhi R; Zhang Q; Montone K; Jalaly JB; Baloch Z
Hum Pathol; 2023 Jun; 136():96-104. PubMed ID: 37054782
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated thyroid carcinoma: A hospital-based clinicopathological study and review of literature.
Win TT; Othman NH; Mohamad I
Indian J Pathol Microbiol; 2017; 60(2):167-171. PubMed ID: 28631629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
